Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

William G. Wierda, John C. Byrd, Jeremy S. Abramson, Syed F. Bilgrami, Greg Bociek, Danielle Brander, Jennifer Brown, Asher A Chanan Khan, Julio C. Chavez, Steve E. Coutre, Randall S. Davis, Christopher D. Fletcher, Brian Hill, Brad S. Kahl, Manali Kamdar, Lawrence D. Kaplan, Nadia Khan, Thomas J. Kipps, Shuo Ma, Sami Malek & 9 others Anthony Mato, Claudio Mosse, Vishala T. Neppalli, Mazyar Shadman, Tanya Siddiqi, Deborah Stephens, Nina Wagner, Mary A. Dwyer, Hema Sundar

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Chronic lymphocytic leukemia (CLL) is generally characterized by an indolent disease course. Histologic transformation (also known as Richter’s transformation) to more aggressive lymphomas, such as diffuse large B-cell lymphoma or Hodgkin lymphoma, occurs in approximately 2% to 10% of patients and is associated with a poor prognosis. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with histologic transformation.

Original languageEnglish (US)
Pages (from-to)12-20
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Lymphoma, Large B-Cell, Diffuse
Hodgkin Disease
Lymphoma
Guidelines

ASJC Scopus subject areas

  • Oncology

Cite this

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., ... Sundar, H. (2019). Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. JNCCN Journal of the National Comprehensive Cancer Network, 17(1), 12-20. https://doi.org/10.6004/jnccn.2019.0002

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. / Wierda, William G.; Byrd, John C.; Abramson, Jeremy S.; Bilgrami, Syed F.; Bociek, Greg; Brander, Danielle; Brown, Jennifer; Chanan Khan, Asher A; Chavez, Julio C.; Coutre, Steve E.; Davis, Randall S.; Fletcher, Christopher D.; Hill, Brian; Kahl, Brad S.; Kamdar, Manali; Kaplan, Lawrence D.; Khan, Nadia; Kipps, Thomas J.; Ma, Shuo; Malek, Sami; Mato, Anthony; Mosse, Claudio; Neppalli, Vishala T.; Shadman, Mazyar; Siddiqi, Tanya; Stephens, Deborah; Wagner, Nina; Dwyer, Mary A.; Sundar, Hema.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 17, No. 1, 01.01.2019, p. 12-20.

Research output: Contribution to journalArticle

Wierda, WG, Byrd, JC, Abramson, JS, Bilgrami, SF, Bociek, G, Brander, D, Brown, J, Chanan Khan, AA, Chavez, JC, Coutre, SE, Davis, RS, Fletcher, CD, Hill, B, Kahl, BS, Kamdar, M, Kaplan, LD, Khan, N, Kipps, TJ, Ma, S, Malek, S, Mato, A, Mosse, C, Neppalli, VT, Shadman, M, Siddiqi, T, Stephens, D, Wagner, N, Dwyer, MA & Sundar, H 2019, 'Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 1, pp. 12-20. https://doi.org/10.6004/jnccn.2019.0002
Wierda, William G. ; Byrd, John C. ; Abramson, Jeremy S. ; Bilgrami, Syed F. ; Bociek, Greg ; Brander, Danielle ; Brown, Jennifer ; Chanan Khan, Asher A ; Chavez, Julio C. ; Coutre, Steve E. ; Davis, Randall S. ; Fletcher, Christopher D. ; Hill, Brian ; Kahl, Brad S. ; Kamdar, Manali ; Kaplan, Lawrence D. ; Khan, Nadia ; Kipps, Thomas J. ; Ma, Shuo ; Malek, Sami ; Mato, Anthony ; Mosse, Claudio ; Neppalli, Vishala T. ; Shadman, Mazyar ; Siddiqi, Tanya ; Stephens, Deborah ; Wagner, Nina ; Dwyer, Mary A. ; Sundar, Hema. / Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. In: JNCCN Journal of the National Comprehensive Cancer Network. 2019 ; Vol. 17, No. 1. pp. 12-20.
@article{6a787460c79c407b8374f059b074fae1,
title = "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019",
abstract = "Chronic lymphocytic leukemia (CLL) is generally characterized by an indolent disease course. Histologic transformation (also known as Richter’s transformation) to more aggressive lymphomas, such as diffuse large B-cell lymphoma or Hodgkin lymphoma, occurs in approximately 2{\%} to 10{\%} of patients and is associated with a poor prognosis. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with histologic transformation.",
author = "Wierda, {William G.} and Byrd, {John C.} and Abramson, {Jeremy S.} and Bilgrami, {Syed F.} and Greg Bociek and Danielle Brander and Jennifer Brown and {Chanan Khan}, {Asher A} and Chavez, {Julio C.} and Coutre, {Steve E.} and Davis, {Randall S.} and Fletcher, {Christopher D.} and Brian Hill and Kahl, {Brad S.} and Manali Kamdar and Kaplan, {Lawrence D.} and Nadia Khan and Kipps, {Thomas J.} and Shuo Ma and Sami Malek and Anthony Mato and Claudio Mosse and Neppalli, {Vishala T.} and Mazyar Shadman and Tanya Siddiqi and Deborah Stephens and Nina Wagner and Dwyer, {Mary A.} and Hema Sundar",
year = "2019",
month = "1",
day = "1",
doi = "10.6004/jnccn.2019.0002",
language = "English (US)",
volume = "17",
pages = "12--20",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

AU - Wierda, William G.

AU - Byrd, John C.

AU - Abramson, Jeremy S.

AU - Bilgrami, Syed F.

AU - Bociek, Greg

AU - Brander, Danielle

AU - Brown, Jennifer

AU - Chanan Khan, Asher A

AU - Chavez, Julio C.

AU - Coutre, Steve E.

AU - Davis, Randall S.

AU - Fletcher, Christopher D.

AU - Hill, Brian

AU - Kahl, Brad S.

AU - Kamdar, Manali

AU - Kaplan, Lawrence D.

AU - Khan, Nadia

AU - Kipps, Thomas J.

AU - Ma, Shuo

AU - Malek, Sami

AU - Mato, Anthony

AU - Mosse, Claudio

AU - Neppalli, Vishala T.

AU - Shadman, Mazyar

AU - Siddiqi, Tanya

AU - Stephens, Deborah

AU - Wagner, Nina

AU - Dwyer, Mary A.

AU - Sundar, Hema

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chronic lymphocytic leukemia (CLL) is generally characterized by an indolent disease course. Histologic transformation (also known as Richter’s transformation) to more aggressive lymphomas, such as diffuse large B-cell lymphoma or Hodgkin lymphoma, occurs in approximately 2% to 10% of patients and is associated with a poor prognosis. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with histologic transformation.

AB - Chronic lymphocytic leukemia (CLL) is generally characterized by an indolent disease course. Histologic transformation (also known as Richter’s transformation) to more aggressive lymphomas, such as diffuse large B-cell lymphoma or Hodgkin lymphoma, occurs in approximately 2% to 10% of patients and is associated with a poor prognosis. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with histologic transformation.

UR - http://www.scopus.com/inward/record.url?scp=85060137075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060137075&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2019.0002

DO - 10.6004/jnccn.2019.0002

M3 - Article

VL - 17

SP - 12

EP - 20

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 1

ER -